Iwarson S, Hermodsson S, Lindholm A, Magnius L
Vox Sang. 1975;28(4):278-84. doi: 10.1111/j.1423-0410.1975.tb02768.x.
Screening for hepatitis B antigen (HB-sAg) in the serum of blood donors and exclusion of antigen-positive blood units have reduced the frequency of post-transfusion hepatitis but several cases of hepatitis B still occur in association with transfusions. One explanation for this is probably that HB-sAg is not an indicator of infectivity. Thus healthy carriers of the antigen seem to have low infectivity while carriers with chronic liver disease as well as donors incubating hepatitis B probably present a great risk.
对献血者血清中的乙肝抗原(HB-sAg)进行筛查并排除抗原阳性的血液单位,已降低了输血后肝炎的发生率,但仍有几例乙型肝炎与输血有关。对此的一种解释可能是HB-sAg并非传染性的指标。因此,抗原的健康携带者似乎传染性较低,而患有慢性肝病的携带者以及正处于乙肝潜伏期的献血者可能具有很大风险。